Guanwei Fan | Cardiovascular research | Best Researcher Award

Published on by Global Academic Awards

Prof. Guanwei Fan | Cardiovascular research | Best Researcher Award

Prof. Guanwei Fan, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China

Prof. Guanwei Fan, PhD, is a prominent researcher at the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, China. His research focuses on the molecular pharmacology of traditional Chinese medicine in cardiovascular diseases. Prof. Fan has received numerous accolades, including recognition as a national “WR” scientific and technological innovation talent and ranking among the top 2% of scientists globally in recent years. He has published extensively, contributing significantly to the understanding of cardiac repair and treatment methodologies. With a strong commitment to advancing traditional medicine, he continues to impact the field profoundly. 📚❤️

 

Publication Profile

Scopus

Education

Prof. Guanwei Fan obtained his Doctoral degree from Tianjin University of Traditional Chinese Medicine (09/2005-06/2008) after earning his Master’s degree from the same institution (09/2002-07/2005). His academic background provides a solid foundation for his research endeavors in traditional Chinese medicine.

Research Direction

Prof. Fan specializes in the molecular pharmacology of traditional Chinese medicine, specifically in the context of cardiovascular diseases. His focus on this area demonstrates his commitment to bridging traditional practices with modern scientific methodologies, contributing valuable insights to the field of pharmacology.

Academic and Professional Achievements

Prof. Fan has garnered significant recognition for his contributions to research and innovation. He has been selected as a national “WR” scientific and technological innovation leading talent and enjoys special government subsidies from The State Council. He is also a national candidate for the Millions of Talents Project and has been recognized as a young and middle-aged scientific and technological innovation leading talent by the Ministry of Science and Technology. Additionally, he holds the title of the first Young Qihuang Scholar and has received multiple accolades, including Tianjin Outstanding Youth and Jinmen Medical Talents. Notably, he ranked among the top 2% of the world’s top scientists in the “Impact of 2022” and “Impact of 2021” lists.

Conclusion

Prof. Guanwei Fan is a highly suitable candidate for the Research for Best Researcher Award. His innovative approach to integrating traditional Chinese medicine with modern pharmacological research in cardiovascular diseases sets him apart as a leading figure in his field.

 

Publication Top Notes  

  • Zhang, K., Yin, Z., Chen, F., … Wang, Y., Fan, G. Omics-based pharmacological evaluation reveals Yuanhu Zhitong oral liquid ameliorates arthritis by regulating PKC/ERK/NF-κB signaling pathway. Journal of Ethnopharmacology, 2024. 📖
  • Liu, Z., Bian, X., Li, L., … Liu, X., Fan, G. SENP1-Mediated HSP90ab1 DeSUMOylation in Cardiomyocytes Prevents Myocardial Fibrosis by Paracrine Signaling. Advanced Science, 2024. 📖
  • Lin, J., Chen, Y., Luo, X., Fan, G. Research hotspots and trends of traditional Chinese and western medicine in treatment of heart failure with preserved ejection fraction. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Feng, C., Jiang, H., Fan, G., Li, L., Feng, J. Retrospective Study on the Efficacy of Qi Li Qiang Xin Jiao Nang in Reducing the Risk of Diuretic Resistance in Patients with Acute Decompensated Chronic Heart Failure. Chinese General Practice, 2024. 📖
  • Shi, J., Yang, M.M., Yang, S., … Fan, G., Ma, C. MaiJiTong granule attenuates atherosclerosis by reducing ferroptosis via activating STAT6-mediated inhibition of DMT1 and SOCS1/p53 pathways in LDLR−/− mice. Phytomedicine, 2024. 📖
  • Li, Z., Lyu, C., Pan, G., … Zhang, B., Huang, Y., Fan, G. Strategies and methods for studying interaction between traditional Chinese and western medicine dominated by clinical benefit-risk signals. Chinese Traditional and Herbal Drugs, 2024. 📖
  • Zhang, K., Ji, J., Li, N., Yin, Z., Fan, G. Integrated Metabolomics and Gut Microbiome Analysis Reveals the Efficacy of a Phytochemical Constituent in the Management of Ulcerative Colitis. Molecular Nutrition and Food Research, 2024. 📖
  • Zhao, Y., Zheng, G., Yang, S., … Fan, G., Ma, C. The plant extract PNS mitigates atherosclerosis via promoting Nrf2-mediated inhibition of ferroptosis through reducing USP2-mediated Keap1 deubiquitination. British Journal of Pharmacology, 2024. 📖
  • Wu, L.-L., Yang, B.-R., Meng, X.-Y., Fan, G.-W., Yang, B. Editorial: Artificial intelligence: new hope for critically ill cardiovascular patients. Frontiers in Medicine, 2024. 📖
  • Zhang, L., Lin, J., Zhang, C., … Fan, G., He, F. Recent Advances in the Nanotechnology-Based Applications of Essential Oils. Current Nanoscience, 2024. 📖

 

 

 

Yael Peled | Heart Transplantation Award | Best Researcher Award

Published on by Global Academic Awards

Prof. Yael Peled | Heart Transplantation Award | Best Researcher Award

Prof. Yael Peled, Sheba Medical Center and Tel Aviv University, Sheba Medical Center and Tel Aviv University

👩‍⚕️ Dr. Yael Peled is a distinguished cardiologist and professor at Tel Aviv University, Israel, renowned for her expertise in heart transplantation and heart failure management. With extensive training and certifications from prestigious institutions worldwide, including Sheba Medical Center and Cedars-Sinai Medical Center, she has excelled in both academia and clinical practice. Dr. Peled’s leadership roles at Sheba Medical Center, along with her contributions to international organizations like the International Society of Heart and Lung Transplantation, highlight her commitment to advancing cardiac care. As a respected educator, researcher, and advocate, she continues to make significant strides in the field of cardiology.

 

Publication Profile

Orcid

Education

 

🎓 Dr. Yael Peled embarked on her academic journey at Tel Aviv University, Israel, where she demonstrated exceptional talent and commitment as an undergraduate student in the Faculty of Life Sciences. Graduating with a B.Sc. degree in Biology with summa cum laude honors in 1996, she earned recognition through the Deans’ excellence scholarship. Dr. Peled’s academic pursuits continued at the esteemed Sackler School of Medicine, Tel Aviv University, where she immersed herself in medical studies from 1996 to 2001. Her dedication culminated in the attainment of her M.D. degree in 2001, marking a significant milestone in her journey toward becoming a highly skilled medical professional. 🩺

 

Research Focus

🔬 Dr. Yael Peled’s research primarily focuses on immunological responses and vaccination strategies in heart transplant recipients, particularly concerning SARS-CoV-2 variants. Through her extensive contributions to journals like The Journal of Heart and Lung Transplantation and Clinical Transplantation, she explores the efficacy of different vaccine formulations, the dynamics of immune response over time, and the implications of donor-recipient characteristics on transplantation outcomes. Dr. Peled’s dedication to understanding these intricacies aims to enhance clinical practices and optimize patient care in the context of heart transplantation and infectious diseases, particularly during the COVID-19 pandemic. 🩺

 

Publication Top Notes

Sixth monovalent XBB.1.5 vaccine elicits robust immune response against emerging SARS-CoV-2 variants in heart transplant recipients

BNT162b2‐vaccine‐induced neutralization responses are immune correlates of clinical protection against SARS‐CoV‐2 in heart transplant recipients

Neutralization of SARS‐CoV‐2 variants elicited by the combination of vaccination and natural infection in heart transplant recipients

Two negatives make a positive: Maximizing heart procurement in adult congenital heart disease

Fifth bivalent omicron BA.4/BA.5 vaccination neutralization of SARS-CoV-2 in heart transplant recipients

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – Implications for the omicron variant: Correspondence

Kinetics of cellular and humoral responses to third BNT162B2 COVID-19 vaccine over six months in heart transplant recipients – implications for the omicron variant